ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 1,056 | +162.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 403 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 403 | -58.2% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 964 | +221.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 300 | +56.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 192 | +8.5% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 177 | -42.7% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 309 | -21.6% | 0.00% | – |
| Q1 2020 | $2,000 | -60.0% | 394 | -43.8% | 0.00% | – |
| Q3 2019 | $5,000 | +150.0% | 701 | +645.7% | 0.00% | – |
| Q2 2019 | $2,000 | – | 94 | +154.1% | 0.00% | – |
| Q1 2019 | $0 | – | 37 | -77.8% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 167 | -16.1% | 0.00% | – |
| Q3 2017 | $2,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 610,045 | $2,014,000 | 0.47% |
| ETF MANAGERS GROUP, LLC | 1,814,328 | $5,987,000 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,169 | $238,000 | 0.06% |
| Bernardo Wealth Planning LLC | 27,219 | $89,000 | 0.03% |
| Affinity Asset Advisors, LLC | 13,285 | $44,000 | 0.02% |
| ALGERT GLOBAL LLC | 20,778 | $69,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $164,000 | 0.01% |
| Founders Capital Management | 2,000 | $18,000 | 0.01% |
| King Wealth Management Group | 16,000 | $53,000 | 0.01% |
| Penserra Capital Management LLC | 129,252 | $425,000 | 0.01% |